NCT03116594View on ClinicalTrials.gov

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

675

Participants

Timeline

Start Date

January 3, 2014

Primary Completion Date

April 8, 2014

Study Completion Date

March 7, 2015

Conditions

Herpes Zoster

Interventions

BIOLOGICAL

NBP608

Preparation of Oka/SK strain of live, attenuated zoster virus

BIOLOGICAL

Zostavax

Preparation of Oka/Merck strain of live, attenuated zoster virus

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT03116594 - Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over | Biotech Hunter | Biotech Hunter